# Macrophage Markers, Soluble CD163 (sCD163) and Soluble CD206 (sCD206) in Paracetamol Overdose

> **NCT03679442** · PHASE1 · COMPLETED · sponsor: **University of Aarhus** · enrollment: 16 (actual)

## Conditions studied

- Drug-Induced Acute Liver Injury

## Interventions

- **DRUG:** N-acetylcysteine

## Key facts

- **NCT ID:** NCT03679442
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09-08
- **Primary completion:** 2015-06-14
- **Final completion:** 2017-02-18
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2018-09-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03679442

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03679442, "Macrophage Markers, Soluble CD163 (sCD163) and Soluble CD206 (sCD206) in Paracetamol Overdose". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03679442. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*